Sorafenib

Drug / MedicationMentioned in 1 video

A drug for liver cancer that could not be treated by surgery. While it extended median survival by about three months in clinical trials, real-world data showed little to no benefit, and it only provided a 50% survival duration compared to the placebo arm in trials.

Videos Mentioning Sorafenib

#133 - Vinay Prasad, M.D., M.P.H: Hallmarks of successful cancer policy

#133 - Vinay Prasad, M.D., M.P.H: Hallmarks of successful cancer policy

Peter Attia MD

A drug for liver cancer that could not be treated by surgery. While it extended median survival by about three months in clinical trials, real-world data showed little to no benefit, and it only provided a 50% survival duration compared to the placebo arm in trials.